Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Momina Krepost ADXBUL:MKR 9 Market Cap is €0.85 Mil as of Aug. 25, 2026. GuruFocus rates XBUL:MKR with a GF Score™ of 9/100 and a GF Value™ of €1.83 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 861 Medical Devices & Instruments companies, Momina Krepost AD ranks worse than 98.37% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Momina Krepost AD's share price for the quarter that ended in Jun. 2026 was €0.98. Momina Krepost AD's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 1.69 Mil. Therefore, Momina Krepost AD's market cap for the quarter that ended in Jun. 2026 was €1.66 Mil.
Momina Krepost AD's quarterly market cap
increased
from Dec. 2025 (€1.78 Mil) to Mar. 2026 (€3.20 Mil) but then
declined
from Mar. 2026 (€3.20 Mil) to Jun. 2026 (€1.66 Mil).
Momina Krepost AD's annual market cap
declined
from Dec. 2023 (€5.41 Mil) to Dec. 2024 (€5.24 Mil) and
declined
from Dec. 2024 (€5.24 Mil) to Dec. 2025 (€1.78 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Momina Krepost AD's Enterprise Value for Today is €1.72 Mil.
Momina Krepost AD (XBUL:MKR) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Momina Krepost AD Market Cap Related Terms
Momina Krepost AD Market Cap Historical Data
* Premium members only.
The historical data trend for Momina Krepost AD's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XBUL:MKR vs ISRG, BDX, MDLN: Market Cap Comparison
For the Medical Instruments & Supplies subindustry, Momina Krepost AD's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Momina Krepost AD Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Momina Krepost AD's Market Cap distribution charts can be found below:
* The bar in red indicates where Momina Krepost AD's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Momina Krepost AD's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momina Krepost AD (XBUL:MKR) has a Market Cap of €0.85 Mil as of Aug. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Momina Krepost AD and its competitors. According to the industry distribution chart, Momina Krepost AD ranks #847 out of 861 companies in the Medical Devices & Instruments industry, placing it in the top 98.4%.
Is Momina Krepost AD's Market Cap too high?
Momina Krepost AD's current Market Cap is €0.85 Mil. Based on the distribution chart, Momina Krepost AD ranks #847 out of 861 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Momina Krepost AD has a GF Score™ of 9/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Momina Krepost AD's Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Momina Krepost AD ranks #847 out of 861 companies for Market Cap. This places Momina Krepost AD in the lower half of its industry. The industry median Market Cap is 122.52. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 122.52, based on 861 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Momina Krepost AD and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 122.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Momina Krepost AD's current Market Cap is €0.85 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Momina Krepost AD stock overvalued right now?
Based on GuruFocus' analysis, Momina Krepost AD (XBUL:MKR) is currently considered Possible Value Trap. The stock's GF Value™ is €1.83, compared to a current price of €0.50 — trading 72.7% below its estimated fair value. The current Market Cap is €0.85 Mil. Momina Krepost AD's overall GF Score™ is 9/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Momina Krepost AD (XBUL:MKR), the current Market Cap is €0.85 Mil as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Momina Krepost AD (XBUL:MKR) Overvalued in 2026?
Based on GuruFocus' analysis, Momina Krepost AD stock appears to be undervalued.
The current stock price of €0.50 is trading 72.7% below its estimated GF Value™ of €1.83.
GuruFocus considers Momina Krepost AD to be Possible Value Trap.
Key valuation signals for XBUL:MKR:
Market Cap: €0.85 Mil
GF Value™: €1.83 vs. price of €0.50 (72.7% below fair value)
No single metric tells the full story. See the XBUL:MKR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Momina Krepost AD is engaged in the production and sales of medical products. The product portfolio includes syringes, injection needles, tubes, catheter, medical clothes, urine collecting bags, among others.
9GF Score
Get the complete analysis for XBUL:MKR
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XBUL:MKR has been successfully added to your 
